Faqeeh Hind, Alsulayyim Rahaf, Assiri Kholoud, Alqhatani Mada, Zanquti Asmaa, Hakami Walaa, Amri Khadijah, Akaram Salva
Obstetrics and Gynecology, AlKhamis Maternity and Children Hospital, Khamis Mushait, SAU.
Obstetrics and Gynecology, King Abdulaziz Hospital, Jeddah, SAU.
Cureus. 2024 Apr 5;16(4):e57646. doi: 10.7759/cureus.57646. eCollection 2024 Apr.
Human papillomavirus (HPV) infection is a prevalent sexually transmitted infection globally, with significant associations with various cancers. Despite the availability of HPV vaccines, vaccination uptake remains suboptimal in many regions, including Saudi Arabia.
This cross-sectional survey-based study aimed to assess perceptions, attitudes, and barriers related to HPV vaccination among residents in different regions of Saudi Arabia. Participants were recruited using a stratified sampling method, and data were collected through a structured questionnaire administered electronically.
A total of 600 participants were included in the study, with diverse demographic profiles observed. The largest age group was 26-35 years old, comprising 42.7% (n = 256) of the sample. The distribution of gender was approximately equal, with 54.7% (n = 328) male participants. Notable perception and knowledge about HPV were observed, with 49.7% (n = 298) reporting being very familiar. Furthermore, 85.8% (n = 515) believed that HPV could cause serious health problems, and 63.7% (n = 382) perceived the vaccine to be very effective. Positive attitudes toward HPV vaccination were prevalent, with a significant proportion expressing a willingness to recommend the vaccine to themselves (70.0%, n = 420) and their children (65.0%, n = 390). Healthcare provider recommendation emerged as a key influencing factor, with 73.8% (n = 443) citing it as influential. Despite favorable attitudes, barriers to HPV vaccination were reported, including vaccine cost (22.5%, n = 135) and lack of awareness (13.7%, n = 82). However, a substantial proportion of unvaccinated participants cited not applicable reasons (57.2%, n = 343), indicating prior vaccination. Factors associated with HPV vaccination uptake included higher education levels, with those holding a master's degree or above exhibiting higher odds of vaccination uptake (OR (odds ratio): 1.80, 95% CI (confidence interval): 1.35-2.40, p < 0.001). Age (26-35 vs. 18-25) also showed a borderline significant association (OR: 1.25, 95% CI: 0.98-1.60, p = 0.074).
The study highlights the importance of understanding perceptions and barriers to HPV vaccination to inform public health policies and programs in Saudi Arabia. Addressing identified barriers, such as educational campaigns and improving access to vaccination services, is essential for enhancing HPV vaccination coverage and reducing the burden of HPV-related diseases in the region.
人乳头瘤病毒(HPV)感染是全球一种普遍的性传播感染,与多种癌症有显著关联。尽管有HPV疫苗,但在包括沙特阿拉伯在内的许多地区,疫苗接种率仍不理想。
这项基于横断面调查的研究旨在评估沙特阿拉伯不同地区居民对HPV疫苗接种的认知、态度和障碍。采用分层抽样方法招募参与者,并通过电子方式发放的结构化问卷收集数据。
共有600名参与者纳入研究,观察到其人口统计学特征多样。最大年龄组为26 - 35岁,占样本的42.7%(n = 256)。性别分布大致相等,男性参与者占54.7%(n = 328)。观察到对HPV有显著的认知和了解,49.7%(n = 298)报告非常熟悉。此外,85.8%(n = 515)认为HPV会导致严重健康问题,63.7%(n = 382)认为疫苗非常有效。对HPV疫苗接种持积极态度很普遍,很大一部分人表示愿意给自己(70.0%,n = 420)和孩子(65.0%,n = 390)推荐疫苗。医疗保健提供者的建议是一个关键影响因素,73.8%(n = 443)将其列为有影响力的因素。尽管态度积极,但报告了HPV疫苗接种的障碍,包括疫苗成本(22.5%,n = 135)和缺乏认识(13.7%,n = 82)。然而,很大一部分未接种疫苗的参与者提到不适用的原因(57.2%,n = 343),表明之前已接种过疫苗。与HPV疫苗接种率相关的因素包括较高的教育水平,拥有硕士学位或以上的人接种疫苗的几率更高(优势比(OR):1.80,95%置信区间(CI):1.35 - 2.40,p < 0.001)。年龄(26 - 35岁与18 - 25岁相比)也显示出临界显著关联(OR:1.25,95% CI:0.98 - 1.60,p = 0.074)。
该研究强调了了解HPV疫苗接种的认知和障碍对于为沙特阿拉伯的公共卫生政策和项目提供信息的重要性。解决已确定的障碍,如开展教育宣传活动和改善疫苗接种服务的可及性,对于提高该地区HPV疫苗接种覆盖率和减轻HPV相关疾病负担至关重要。